U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282405) titled 'Validation of Alcohol Level Identification Using DRIVESC' on Dec. 02.
Brief Summary: This pilot study will evaluate the feasibility and acceptability of using a commercially available DRIVESC fitness-to-drive measurement tool to detect alcohol-induced impairment in healthy adult participants. The investigators hypothesize that DRIVESC can detect measurable changes in driving-related cognitive and motor performance across blood alcohol concentrations up to the U.S. per se legal limit of 0.08% g/210L ethanol. The study will enroll healthy adults aged 18-64 years (including both dosed and zero-alcohol arms) participating in the Wiscons...